Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and β2-microgiobulin-deficient mouse

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6912-6917

  Sohn, Kyoung Jin ^a   Shah, Samir A ^c   Reid, Sarah ^a   Choi, Monica ^a   Carrier, Julie ^a   Comiskey, Martina ^d   Terhorst, Cox ^d   Kim, Young In ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c BROWN UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOSINE; DNA; GUANINE; INTERLEUKIN 2; PROTEIN P53;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; MOLECULAR GENETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ADENOCARCINOMA; ANIMALS; BETA 2-MICROGLOBULIN; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FRAMESHIFT MUTATION; GENES, APC; GENES, P53; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICROSATELLITE REPEATS; MUTATION, MISSENSE;

EID: 0035884596     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Inflammatory bowel disease and cancer
2. Ulcerative colitis and colorectal cancer. A population based study
3. Molecular genetics of colorectal cancer
4. Lessons from hereditary colorectal cancer
5. Loss of heterozygosity affecting the p53, Rb. and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis
6. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias
7. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms
8. Frequent loss of a p 53 allele in carcinomas and their precursors in ulcerative colitis
9. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis
10. Molecular genetic profiles of colitis-associated neoplasms
11. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
12. Neoplastic progression in ulcerative colitis: Histology. DNA content, and loss of a p53 allele
13. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions
14. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma
15. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long standing ulcerative colitis
16. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: AS cancer-prone chronic inflammatory disease
17. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma
18. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis
19. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis
20. Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products
21. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis
22. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers
23. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia
24. Microsatellite instability and K-ras mutations in patients with ulcerative colitis
25. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis
26. Experimental models of inflammatory bowel disease
27. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
28. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis
29. Development of colonic adenocarcinomas in a mouse model of ulcerative colitis
30. Effects of dietary folate on colorectal carcinogenesis in a genetically-predisposed murine model of ulcerative colitis-associated colon cancer
31. The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer
32. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice
33. APC gene: Database of germline and somatic mutations in human tumors and cell lines
34. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene [published erratum appears in Science (Wash. DC), 256: 1114, 1992]
35. p53 mutations in human cancers
36. Analysis of the gene coding for the murine cellular tumour antigen p53
37. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis
38. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats
39. Somatic Apc mutations are selected upon their capacity to inactivate the β-catenin downregulating activity
40. Tumor-associated Apc mutations in Mlh1-/-Apc 1638N mice reveal a mutational signature of Mlh1 deficiency
41. Effects of dietary folate on somatic AFC mutations in APC+/-MSH2-/- mice
42. Lens epithelial cells derived from αB-crystallin knockout mice demonstrate hyperproliferation and genomic instability
43. Polyploidization induced by acridine orange in mouse osteosarcoma cells
44. Overproduction of MDM 2 in vivo disrupts S phase independent of E2F1
45. DNA mismatch repair and cancer
46. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
47. Promotion of colorectal neoplasia in experimental murine ulcerative colitis
48. Histochemical study of colonic cancer in experimental colitis of rats
49. No involvement of Ki-ras or p53 gene mutations in colitis associated rat colon tumors induced by I-hydroxyanthraquinone and methylazoxymethanol acetate
50. No involvement of APC gene mutations in ulcerative colitis-associated rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate
51. Interleukin-10-deficient develop chronic enterocolitis
52. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
53. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
54. Inflammatory bowel disease and adenomas in nitre expressing a dominant negative N-cadherin
55. Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice
56. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: An animal model of HLA-B27-associated human disorders
57. High prevalence of colorectal cancer in HLA-B 27 transgenic F344 rats with chronic inflammatory bowel disease
58. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
59. Folate and carcinogenesis: Evidence, mechanisms and implications
60. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model
61. Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
62. Colorectal cancer prevention in ulcerative colitis: A case-control study